PYURF
gene geneOn this page
Also known as PreY
Summary
PYURF (PIGY upstream open reading frame, HGNC:44317) is a protein-coding gene on chromosome 4q22.1, encoding Protein preY, mitochondrial (Q96I23). In mitochondria, S-adenosylmethionine-dependent methyltransferase chaperone that supports both coenzyme Q biosynthesis, by stabilizing its components, such as COQ5, and NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) assembly, by stabilizing complex I assembly factors…. It is a selective cancer dependency (DepMap: 26.0% of cell lines).
The product of this gene, which is well-conserved, is encoded by the same bicistronic transcript that encodes phosphatidylinositol glycan anchor biosynthesis, class Y, but the two proteins are unrelated. This gene represents the protein encoded by the upstream open reading frame, while the protein encoded by the downstream open reading frame is represented by GeneID:84992.
Source: NCBI Gene 100996939 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 1 total
- Cancer dependency (DepMap): dependent in 26.0% of screened cell lines
- MANE Select transcript:
NM_032906
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44317 |
| Approved symbol | PYURF |
| Name | PIGY upstream open reading frame |
| Location | 4q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PreY |
| Ensembl gene | ENSG00000145337 |
| Ensembl biotype | protein_coding |
| OMIM | 619956 |
| Entrez | 100996939 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000273968
RefSeq mRNA: 1 — MANE Select: NM_032906
NM_032906
CCDS: CCDS3631
Canonical transcript exons
ENST00000273968 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000970016 | 88523498 | 88523776 |
| ENSE00001244874 | 88520998 | 88522029 |
Expression profiles
Bgee: expression breadth ubiquitous, 143 present calls, max score 94.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 67.6767 / max 805.1876, expressed in 1824 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 53098 | 67.6767 | 1824 |
Top tissues by expression
143 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| islet of Langerhans | UBERON:0000006 | 94.50 | gold quality |
| spinal cord | UBERON:0002240 | 94.21 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.21 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 94.11 | gold quality |
| body of pancreas | UBERON:0001150 | 94.11 | gold quality |
| pancreas | UBERON:0001264 | 94.03 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.82 | gold quality |
| left coronary artery | UBERON:0001626 | 93.81 | gold quality |
| left uterine tube | UBERON:0001303 | 93.78 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.78 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.72 | gold quality |
| monocyte | CL:0000576 | 93.67 | gold quality |
| leukocyte | CL:0000738 | 93.67 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.66 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 93.62 | gold quality |
| endometrium | UBERON:0001295 | 93.61 | gold quality |
| popliteal artery | UBERON:0002250 | 93.57 | gold quality |
| fallopian tube | UBERON:0003889 | 93.57 | gold quality |
| tibial artery | UBERON:0007610 | 93.57 | gold quality |
| substantia nigra | UBERON:0002038 | 93.48 | gold quality |
| body of uterus | UBERON:0009853 | 93.44 | gold quality |
| hypothalamus | UBERON:0001898 | 93.37 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 93.36 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.35 | gold quality |
| ectocervix | UBERON:0012249 | 93.31 | gold quality |
| adipose tissue | UBERON:0001013 | 93.27 | gold quality |
| ventricular zone | UBERON:0003053 | 93.26 | gold quality |
| thoracic aorta | UBERON:0001515 | 93.22 | gold quality |
| omental fat pad | UBERON:0010414 | 93.18 | gold quality |
| ascending aorta | UBERON:0001496 | 93.17 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10042 | yes | 5.67 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
75 targeting PYURF, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-105-5P | 99.54 | 69.24 | 2060 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 26.0% of screened cell lines.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | PYURF | ENSDARG00000045773 |
| rattus_norvegicus | Pyurf | ENSRNOG00000006858 |
Protein
Protein identifiers
Protein preY, mitochondrial — Q96I23 (reviewed: Q96I23)
Alternative names: PIGY upstream reading frame protein
All UniProt accessions (1): Q96I23
UniProt curated annotations — full annotation on UniProt →
Function. In mitochondria, S-adenosylmethionine-dependent methyltransferase chaperone that supports both coenzyme Q biosynthesis, by stabilizing its components, such as COQ5, and NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) assembly, by stabilizing complex I assembly factors, such as NDUFAF5.
Subunit / interactions. Interacts (via TRM112 domain) with NDUFAF5; the interaction is direct and stabilizes NDUFAF5 protein. Interacts with COQ5; the interaction is direct, stabilizes COQ5 protein and associates PYURF with COQ enzyme complex.
Subcellular location. Mitochondrion.
Disease relevance. An homozygous frameshift variant in the second exon of PYURF have been found in a patient with profound metabolic acidosis and clinical features including muscle hypotonia, failure to thrive, developmental delay, optic atrophy, persistently elevated lactate levels in the blood and cerebrospinal fluid, and abnormal cerebellar white matter and cerebellar atrophy on magnetic resonance imaging.
Miscellaneous. PREY and PIGY, 2 apparently unrelated proteins, are respectively the product of an upstream and a downstream ORF contained in a single bicistronic transcript.
Similarity. Belongs to the PREY family.
RefSeq proteins (1): NP_116295* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005651 | Trm112-like | Family |
Pfam: PF03966
UniProt features (8 total): mutagenesis site 3, transit peptide 1, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96I23-F1 | 77.09 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 58 | loss of interaction with ndufaf5. |
| 60 | reduces interaction with ndufaf5. |
| 91 | reduces interaction with ndufaf5. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6799198 | Complex I biogenesis |
MSigDB gene sets: 44 (showing top):
GOBP_PROTEIN_STABILIZATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, chr4q22, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, DELACROIX_RARG_BOUND_MEF, REACTOME_COMPLEX_I_BIOGENESIS, CSHL1_TARGET_GENES, TOP2B_TARGET_GENES, ZNF7_TARGET_GENES, ZNF711_TARGET_GENES, MIR548E_5P, MIR6809_3P, MIR137_3P, MIR5680
GO Biological Process (1): protein stabilization (GO:0050821)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): mitochondrion (GO:0005739), endoplasmic reticulum membrane (GO:0005789)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of protein stability | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
Protein interactions and networks
STRING
408 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PYURF | PIGY | Q3MUY2 | 911 |
| PYURF | PIGP | P57054 | 882 |
| PYURF | PIGH | Q14442 | 840 |
| PYURF | PIGC | Q92535 | 840 |
| PYURF | PIGA | P37287 | 828 |
| PYURF | PIGQ | Q9BRB3 | 807 |
| PYURF | DPM2 | O94777 | 805 |
| PYURF | NDUFAF5 | Q5TEU4 | 544 |
| PYURF | BEAN1 | Q3B7T3 | 532 |
| PYURF | FAM13A | O94988 | 530 |
| PYURF | ZNF608 | Q9ULD9 | 504 |
| PYURF | RIMS4 | Q9H426 | 501 |
| PYURF | TUBGCP4 | Q9UGJ1 | 490 |
| PYURF | TRUB2 | O95900 | 474 |
| PYURF | PCYOX1 | Q9UHG3 | 471 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COQ5 | COQ9 | psi-mi:“MI:0914”(association) | 0.590 |
| PB2 | psi-mi:“MI:0914”(association) | 0.350 | |
| VWA8 | psi-mi:“MI:2364”(proximity) | 0.270 | |
| PDK1 | VWA8 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (7): PYURF (Affinity Capture-MS), PYURF (Proximity Label-MS), PYURF (Co-fractionation), HEBP1 (Co-fractionation), HINT2 (Co-fractionation), PYURF (Co-fractionation), PYURF (Co-fractionation)
ESM2 similar proteins: A4D161, B1AR13, D3ZV31, E1BBQ2, E1BGQ2, F1N2W9, O42148, O42224, O70524, O95453, P0C7P0, P56726, P97698, Q2T9V7, Q3UGM2, Q497H0, Q56K12, Q5RC51, Q5T6S3, Q5U2M7, Q5XII8, Q5ZIA0, Q60769, Q66J85, Q6DDJ3, Q6DJB3, Q6ZN54, Q7T0P6, Q7Z2E3, Q8BKW4, Q8BYN3, Q8CCA0, Q8IWR0, Q8K214, Q8K2I9, Q8NE86, Q8NFZ0, Q8TDW4, Q92564, Q96GD3
Diamond homologs: A0K9W9, A1B4L5, A1TQ98, A1V115, A1W893, A1WSH4, A2S514, A3MN46, A3N6K6, A3NS89, A3PFZ5, A4JH78, A4WWL8, A4YK44, A5CVZ8, A5E8U9, A5VVG4, A5W727, A6UDZ3, A6V3B8, A6X438, A9AGK3, A9BWI3, A9H298, A9MCH2, A9WVQ6, B0KF42, B0UM25, B1J507, B1JXF6, B1YVD8, B2JDV3, B2SAE8, B2T6M2, B3PR35, B3Q881, B4E9F9, B5ZTJ9, B7V148, B8GR39
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
236 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:88522025:CATAT:C | acceptor_gain | 1.0000 |
| 4:88522027:TAT:T | acceptor_gain | 1.0000 |
| 4:88522030:C:CC | acceptor_gain | 1.0000 |
| 4:88522035:G:GC | acceptor_gain | 1.0000 |
| 4:88523495:TACCT:T | donor_loss | 1.0000 |
| 4:88523496:ACCTG:A | donor_loss | 1.0000 |
| 4:88523497:C:CG | donor_loss | 1.0000 |
| 4:88522028:AT:A | acceptor_gain | 0.9900 |
| 4:88522029:TCTGA:T | acceptor_loss | 0.9900 |
| 4:88522030:C:A | acceptor_loss | 0.9900 |
| 4:88522031:T:A | acceptor_loss | 0.9900 |
| 4:88522035:G:C | acceptor_gain | 0.9900 |
| 4:88522899:T:C | donor_gain | 0.9900 |
| 4:88523496:A:AC | donor_gain | 0.9900 |
| 4:88523497:C:CC | donor_gain | 0.9900 |
| 4:88522888:A:AC | donor_gain | 0.9700 |
| 4:88522889:C:CC | donor_gain | 0.9700 |
| 4:88522026:ATAT:A | acceptor_gain | 0.9600 |
| 4:88523508:T:TA | donor_gain | 0.9400 |
| 4:88522105:C:CT | donor_gain | 0.9300 |
| 4:88522881:CAACA:C | donor_gain | 0.9200 |
| 4:88522882:AACAA:A | donor_gain | 0.9200 |
| 4:88522860:TTC:T | donor_gain | 0.8900 |
| 4:88522890:T:C | donor_gain | 0.8900 |
| 4:88522856:CACTT:C | donor_gain | 0.8200 |
| 4:88522861:T:A | donor_gain | 0.8200 |
| 4:88522884:CA:C | donor_gain | 0.8100 |
| 4:88522885:AA:A | donor_gain | 0.8100 |
| 4:88522816:G:C | donor_gain | 0.8000 |
| 4:88522980:TAGGG:T | donor_gain | 0.8000 |
AlphaMissense
722 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:88522006:A:G | L76S | 0.969 |
| 4:88521961:A:G | I91T | 0.949 |
| 4:88521999:A:C | N78K | 0.947 |
| 4:88521999:A:T | N78K | 0.947 |
| 4:88523509:C:A | K64N | 0.941 |
| 4:88523509:C:G | K64N | 0.941 |
| 4:88523523:A:G | C60R | 0.939 |
| 4:88523513:G:A | S63F | 0.933 |
| 4:88521937:G:T | A99D | 0.919 |
| 4:88521961:A:C | I91S | 0.913 |
| 4:88521964:C:A | G90V | 0.913 |
| 4:88521973:A:T | I87N | 0.912 |
| 4:88523501:A:T | L67H | 0.911 |
| 4:88521973:A:C | I87S | 0.910 |
| 4:88521959:G:A | P92S | 0.903 |
| 4:88521980:A:C | Y85D | 0.901 |
| 4:88521958:G:T | P92H | 0.900 |
| 4:88521951:C:A | M94I | 0.899 |
| 4:88521951:C:G | M94I | 0.899 |
| 4:88521951:C:T | M94I | 0.899 |
| 4:88521973:A:G | I87T | 0.890 |
| 4:88523522:C:G | C60S | 0.887 |
| 4:88523523:A:T | C60S | 0.887 |
| 4:88521952:A:G | M94T | 0.886 |
| 4:88523521:G:C | C60W | 0.885 |
| 4:88521982:G:T | A84D | 0.880 |
| 4:88521980:A:G | Y85H | 0.877 |
| 4:88521959:G:T | P92T | 0.876 |
| 4:88523530:G:C | F57L | 0.876 |
| 4:88523530:G:T | F57L | 0.876 |
dbSNP variants (sampled 300 via entrez): RS1000114967 (4:88524116 A>G), RS1001758000 (4:88522465 G>A), RS1002219622 (4:88520843 G>C), RS1002830216 (4:88524919 T>C), RS1002909692 (4:88523771 G>C,T), RS1002960516 (4:88524597 G>A), RS1004315038 (4:88520856 C>T), RS1004791959 (4:88524244 G>T), RS1005938437 (4:88524735 G>A,C), RS1006383836 (4:88525002 G>GT), RS1007645802 (4:88523822 C>G,T), RS1007950891 (4:88521933 C>A), RS1008028290 (4:88523657 C>A,T), RS1008397665 (4:88522297 T>C), RS1009023330 (4:88524010 T>C)
Disease associations
OMIM: gene MIM:619956 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005956_59 | Waist-to-hip ratio adjusted for BMI | 5.000000e-08 |
| GCST005957_14 | Waist-to-hip ratio adjusted for BMI (age <50) | 2.000000e-06 |
| GCST005962_35 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 2.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cadmium | decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TH87 | HAP1 PYURF (-) 1 | Cancer cell line | Male |
| CVCL_TH88 | HAP1 PYURF (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.